News

G20 2017 Leaders’ Declaration: Shaping an interconnected world --Combatting Antimicrobial Resistance via a One Health Approach-- From The Weekend Australian http://www.theaustralian.com.au/ SEE http://www.theaustralian.com.au/news/world/g20-2017-leaders-declaration-shaping-an-interconnected-world/news-story/27e752cd6768607df06e0f1569333cac or https://goo.gl/ZT65rf.   “Combatting Antimicrobial Resistance (AMR): AMR represents a growing threat to public health and economic growth. To tackle the spread of AMR in humans, animals and the environment, we aim to have implementation of our National Action Plans, based on a One-Health approach, well under way by the end of 2018. We will promote the prudent use of antibiotics (Noting differences in the G20 country definitions of the term “antibiotics” and referring here to those antibiotics with an impact on human health, including those antimicrobials that are critically important for human medicine as defined by the WHO.) in all sectors and strive to restrict their use in veterinary medicine to therapeutic uses alone. Responsible and prudent use of antibiotics in food producing animals does not include the use for growth promotion in the absence of risk analysis. We underline that treatments should be available through prescription or the veterinary equivalent only. We will strengthen public awareness, infection prevention and control and improve the understanding of the issue of antimicrobials in the environment. We will promote access to affordable and quality antimicrobials, vaccines and diagnostics, including through efforts to preserve existing therapeutic options. We highlight the importance of fostering R&D, in particular for priority pathogens as identified by the WHO and tuberculosis. We call for a new international R&D Collaboration Hub to maximise the impact of existing and new anti-microbial basic and clinical research initiatives as well as product development. We invite all interested countries and partners to join this new initiative. Concurrently, in collaboration with relevant experts including from the OECD and the WHO, we will further examine practical market incentive options.”